Latest News


Each news article below shows only part of the news story. To view the full story, click on Read More below the story. 

<< First  < Prev   1   2   3   4   5   ...   Next >  Last >> 
  • March 03, 2020 7:58 AM | Becca Liebers (Administrator)

    MedPage Today

    Study details aspirin nonadherence impacts on obstetric complications

    Greater aspirin adherence was associated with better preeclampsia prevention in high-risk pregnancies, according to an observational cohort study.

    Inadequate adherence, seen in 63 of 145 women prescribed prophylactic aspirin in the study from Australia, was linked to a higher incidence of:

    Early-onset preeclampsia (17% vs 2% with adequate adherence, OR 1.9, 95% CI 1.1-8.7)

    Late-onset preeclampsia (41% vs 5%, OR 4.2, 95% CI 1.4-19.8)

    Intrauterine growth restriction (29% vs 5%, OR 5.8, 95% CI 1.2-8.3)

    Preterm delivery (27% vs 10%, OR 5.2, 95% CI 1.5-8.7)

    Increase in antihypertensive use antenatally (60% vs 10%, OR 4.6, 95% CI 1.2-10.5)

    Good aspirin compliance was linked to lower odds of premature delivery -- the only treatment for preeclampsia -- on Kaplan-Meier analysis (HR 0.3, 95% CI 0.2-0.5), a study team led by Renuka Shanmugalingam, MBBS, of Liverpool Hospital in Australia, reported online in the Hypertension journal.

    With an absolute risk reduction of 51% and number needed to treat of just two when adherence is ≥90%, the authors concluded that aspirin is "an effective prophylactic agent" for the prevention of preeclampsia.

    "Therefore, suggesting adequate adherence with aspirin is essential and that nonadherence with aspirin among high-risk pregnant women may result in preventable obstetric complications," they urged.

    They acknowledged, however, that aspirin for preeclampsia prophylaxis "remains controversial" because of conflicting data.

    Read more.

  • February 19, 2020 7:43 AM | Becca Liebers (Administrator)

    ACOG Today's Headline / Chicago Tribune

    Less than 5% of pregnant women have good heart health, according to Northwestern study. Experts say doctors need to do more in response.

    Cardiovascular disease is the leading cause of death during pregnancy and the postpartum period, and U.S. health experts are working to better understand why so many moms are dying.

    But many women might be unaware of their heart risks while pregnant — and the importance of taking steps to improve heart health is becoming more clear in light of a new study.

    On Monday, Northwestern Medicine researchers published what they say is the first study to examine the cardiovascular health of pregnant women in the United States.

    Using 15 years of data from the Centers for Disease Control and Prevention’s National Health and Nutrition Examination Survey, the Journal of the American Heart Association article analyzed records of 1,117 pregnant and 8,200 nonpregnant women, assessing key factors including diet, exercise and blood pressure.

    Read more.

  • February 16, 2020 8:24 AM | Becca Liebers (Administrator)

    Medium / Surabhi Verma

    "My name is Kristy Goodman and I’m the Co-founder & CEO of PreConception, the first and only direct-to-consumer preconception testing platform for women planning a pregnancy. My background is in medicine and I worked as a women’s health PA for several years before starting PreConception. Working in Ob/Gyn I realized how few women were receiving appropriate preconception testing and education before pregnancy and decided to leave clinical practice to start PreConception and bring preconception testing to women across the country through an online platform."

    Read the full article here!

  • February 10, 2020 8:45 AM | Becca Liebers (Administrator)

    ACOG Today's Headlines / MedPage Today

    MedPage Today (2/7, D'Ambrosio) reported research based on CDC data from 2003 to 2016 revealed a decrease in maternal deaths in medical facilities. However, over the same period, “the rate of pregnancy-related deaths in the home nearly doubled.” Moreover, “increases in pregnancy-related death rates during this period were most dramatic in women age 45 and older,” according to a presentation at the Society for Maternal-Fetal Medicine annual meeting.

    Read more.

  • February 07, 2020 8:42 AM | Becca Liebers (Administrator)

    ACOG Today's Headline / CBS NEWS

    CBS News (2/7) reported “heart disease is known to kill nearly 420,000 women in the U.S. each year, and is the leading cause of maternal deaths.” Moreover, “We’re seeing that there’s actually an increase in the number of heart attacks during pregnancy, and that number is going up in the United States,” one cardiologist told CBS news. In addition, research published in the National Vital Statistics Report “found that about one in four pregnancy or postpartum deaths are caused by cardiovascular complications – hypertensive disorders in particular affect as many as one in 10 women and cause increased risk of heart failure, heart attack, and stroke.” 

    Read more.

  • December 02, 2019 12:34 PM | Becca Liebers (Administrator)

    Journal of the American Academy of Physician Assistants: December 2019 - Volume 32 - Issue 12 - p 11–12

    Gajarawala, Shilpa N. DMSc, MPAS, PA-C; Wood, Tiffany A. BSHS; Stanton, Amanda P. MHS, PA-C

    ABSTRACT In small clinical trials, dehydroepiandrosterone (DHEA) has been found to relieve symptoms associated with postmenopausal conditions and infertility in women. DHEA may provide a cost-effective alternative to typical hormone therapies. Because of a lack of long-term and large-scale studies, only intravaginal DHEA supplementation is approved and recommended for treatment. Further investigation of DHEA supplementation is needed and encouraged to determine its safety and effectiveness.

    AAPA Members can view Full text articles for FREE. Not a Member? Join today!

  • November 21, 2019 1:30 PM | Becca Liebers (Administrator)

    Washington, D.C. – Ted L. Anderson, MD, PhD, president of the American College of Obstetricians and Gynecologists (ACOG), issued the following statement regarding the vote out of the House Energy and Commerce Committee on H.R. 4995 and H.R. 4996: 

    “ACOG applauds the House Energy and Commerce Committee for advancing H.R. 4995 and H.R. 4996. The committee took a giant step toward eliminating preventable maternal deaths with these two critically important bills that will improve maternal health outcomes and build upon legislation passed last year.

    “These bills include ACOG’s top legislative priorities in the “Momnibus,” a collection of U.S. House and Senate bills aimed at addressing the maternal mortality crisis. Specifically, H.R. 4995 and H.R. 4996 will 

    • help hospitals and maternity care providers implement clinically proven best practices,
    • incentivize states to continue Medicaid or CHIP coverage for women for one year after delivery,
    • increase access to maternity care in rural and underserved areas,
    • work to eliminate racial and ethnic disparities in maternal health, and
    • provide support for perinatal quality collaboratives.

    “Typically, women lose Medicaid coverage 60 days after delivery. This legislation would help ensure that moms receive care beyond that period for serious health conditions, including cardiovascular disease, postpartum depression, and opioid use, and close a huge gap in women’s health coverage during a time in which the Centers for Disease Control and Prevention show one-third of preventable maternal deaths occur.

    "ACOG is very appreciative of House Energy and Commerce Chairman Frank Pallone and Ranking Member Greg Walden; Health Subcommittee Chairwoman Anna Eshoo and Ranking Member Michael Burgess, MD, FACOG; and Representatives Robin Kelly, Larry Bucshon, MD, Eliot Engel, and many more. It’s notable that the committee members are working across the aisle to deliver solutions to the nation’s maternal mortality crisis. We applaud their work and look forward to collaborating with all members of Congress to bring these bills to the floor of the House and Senate.”

    To learn more about recent state action to extend Medicaid coverage to pregnant women for a year after delivery, view ACOG’s map.

  • November 13, 2019 3:26 PM | Becca Liebers (Administrator)

    APAOG Member Benefits

    With over 250 members, the Association for Physician Assistants in Obstetrics and Gynecology is the only professional association devoted exclusively to PAs practicing in women's health. Established in 1991, APAOG is the collective voice for professionals working to improve the health care of women.

    APAOG commitment to its members:

    • To advocate for patient autonomy through education and collaborative care.
    • To promote clinical and academic excellence for members of APAOG.
    • To provide members with a forum to discuss topics that relate to PA's practicing in women's health.
    • To assist and support PA's and the healthcare team by providing information through education and programs relating to the delivery of quality women's healthcare services.

    Benefits of Membership 

    Download an APAOG Membership Flyer Here

    JOIN or Renew Today!
  • October 06, 2019 1:07 PM | Becca Liebers (Administrator)

    October 6-12, AAPA

    Every year from October 6-12, we celebrate National PA Week, which recognizes the PA profession and its contributions to the nation’s health.

    This week is also an opportunity to raise awareness and visibility of the profession. Before it was a week-long event, National PA Day was first celebrated on October 6, 1987, in honor of the 20th anniversary of the first graduating class of PAs from the Duke University PA program. October 6 is also the birthday of the profession’s founder, Eugene A. Stead, Jr., MD.

    More information here!

    Visit along on our facebook page

  • August 26, 2019 3:38 PM | Becca Liebers (Administrator)

    August 25, 2019 - MedPage Today

    Per the final two-part recommendation published at the USPSTF website and in JAMA, assessments for increased risk of BRCA1 and BRCA2 genetic mutations should be conducted in women who have a personal or family history of certain types of cancers (breast, ovarian, fallopian tube, or peritoneal cancers), or who have an ancestry associated with BRCA1 or BRCA2 mutations. Women found to be at increased risk should receive genetic counseling and, if indicated after counseling, BRCA testing. The first part of the recommendation received a 'B' grade, meaning a "high certainty that the net benefit is moderate or there is moderate certainty that the net benefit is moderate to substantial."

    Read More.

<< First  < Prev   1   2   3   4   5   ...   Next >  Last >> 
Powered by Wild Apricot Membership Software